These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 11500813)

  • 21. Tissue engineering of heart valves: advances and current challenges.
    Mol A; Smits AI; Bouten CV; Baaijens FP
    Expert Rev Med Devices; 2009 May; 6(3):259-75. PubMed ID: 19419284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cells for tissue engineering of cardiac valves.
    Jana S; Tranquillo RT; Lerman A
    J Tissue Eng Regen Med; 2016 Oct; 10(10):804-824. PubMed ID: 25712485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design Approaches to Myocardial and Vascular Tissue Engineering.
    Akintewe OO; Roberts EG; Rim NG; Ferguson MAH; Wong JY
    Annu Rev Biomed Eng; 2017 Jun; 19():389-414. PubMed ID: 28471698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 6-month aortic valve implantation of an off-the-shelf tissue-engineered valve in sheep.
    Syedain Z; Reimer J; Schmidt J; Lahti M; Berry J; Bianco R; Tranquillo RT
    Biomaterials; 2015 Dec; 73():175-84. PubMed ID: 26409002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular Tissue Engineering: Preclinical Validation to Bedside Application.
    Best C; Onwuka E; Pepper V; Sams M; Breuer J; Breuer C
    Physiology (Bethesda); 2016 Jan; 31(1):7-15. PubMed ID: 26661524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress in developing a living human tissue-engineered tri-leaflet heart valve assembled from tissue produced by the self-assembly approach.
    Dubé J; Bourget JM; Gauvin R; Lafrance H; Roberge CJ; Auger FA; Germain L
    Acta Biomater; 2014 Aug; 10(8):3563-70. PubMed ID: 24813743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relevance of large strains in functional tissue engineering of heart valves.
    Mol A; Bouten CV; Zünd G; Günter CI; Visjager JF; Turina MI; Baaijens FP; Hoerstrup SP
    Thorac Cardiovasc Surg; 2003 Apr; 51(2):78-83. PubMed ID: 12730815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autologous human tissue-engineered heart valves: prospects for systemic application.
    Mol A; Rutten MC; Driessen NJ; Bouten CV; Zünd G; Baaijens FP; Hoerstrup SP
    Circulation; 2006 Jul; 114(1 Suppl):I152-8. PubMed ID: 16820565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineering of vascular ingrowth matrices: are protein domains an alternative to peptides?
    Merzkirch C; Davies N; Zilla P
    Anat Rec; 2001 Aug; 263(4):379-87. PubMed ID: 11500815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-related structural changes in cardiac valves: implications for tissue-engineered repairs.
    Barzilla JE; Blevins TL; Grande-Allen KJ
    Am J Geriatr Cardiol; 2006; 15(5):311-5. PubMed ID: 16957451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and characterization of tissue-engineered aortic valves.
    Zeltinger J; Landeen LK; Alexander HG; Kidd ID; Sibanda B
    Tissue Eng; 2001 Feb; 7(1):9-22. PubMed ID: 11224920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomechanical properties of native and tissue engineered heart valve constructs.
    Hasan A; Ragaert K; Swieszkowski W; Selimović S; Paul A; Camci-Unal G; Mofrad MR; Khademhosseini A
    J Biomech; 2014 Jun; 47(9):1949-63. PubMed ID: 24290137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From stem cells to viable autologous semilunar heart valve.
    Sutherland FW; Perry TE; Yu Y; Sherwood MC; Rabkin E; Masuda Y; Garcia GA; McLellan DL; Engelmayr GC; Sacks MS; Schoen FJ; Mayer JE
    Circulation; 2005 May; 111(21):2783-91. PubMed ID: 15927990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenges in developing a reseeded, tissue-engineered aortic valve prosthesis.
    Hof A; Raschke S; Baier K; Nehrenheim L; Selig JI; Schomaker M; Lichtenberg A; Meyer H; Akhyari P
    Eur J Cardiothorac Surg; 2016 Sep; 50(3):446-55. PubMed ID: 27084195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.
    Engelmayr GC; Sales VL; Mayer JE; Sacks MS
    Biomaterials; 2006 Dec; 27(36):6083-95. PubMed ID: 16930686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
    Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
    Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue engineering of cardiovascular structures.
    Mayer JE; Shin'oka T; Shum-Tim D
    Curr Opin Cardiol; 1997 Nov; 12(6):528-32. PubMed ID: 9429823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cardiovascular tissue-reactor: a novel device for the engineering of heart valves.
    Karim N; Golz K; Bader A
    Artif Organs; 2006 Oct; 30(10):809-14. PubMed ID: 17026581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue engineering approaches utility.
    Mitka M
    JAMA; 2000 Nov 22-29; 284(20):2582-3. PubMed ID: 11086348
    [No Abstract]   [Full Text] [Related]  

  • 40. Bioengineering strategies for polymeric scaffold for tissue engineering an aortic heart valve: an update.
    Morsi YS
    Int J Artif Organs; 2014 Sep; 37(9):651-67. PubMed ID: 25262629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.